|
[1]
|
Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, et al. Planning and developing population-based cancer registration in low-and middle-income settings. Lyon: International Agency for Research on Cancer; 2014. IARC Technical Publication No. 43. https://www.who.int/immunization/hpv/iarc_technical_report_no43.pdf.https://www.who.int/immunization/hpv/iarc_technical_report_no43.pdf |
|
[2]
|
Wei WQ, Zeng HM, Zheng RS, Zhang SW, An L, Chen R, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol 2020;21(7):e342 − 9. http://dx.doi.org/10.1016/s1470-2045(20)30073-5CrossRef
|
|
[3]
|
He J, Wei WQ. 2019 China cancer registry annual report. Beijing: People’s Medical Publishing House. 2021. https://www.dushu.com/book/13807902/. (In Chinese). https://www.dushu.com/book/13807902/ |
|
[4]
|
Barber SL, Yao L. Health insurance systems in China: a briefing note. Geneva: World Health Organization; 2010. World Health Report (2010) Background Paper, No. 37. https://www.who.int/healthsystems/topics/financing/healthreport/37ChinaB_YFINAL.pdf. [2020-10-23].https://www.who.int/healthsystems/topics/financing/healthreport/37ChinaB_YFINAL.pdf |
|
[5]
|
Shi C, Liu MF, Liu Z, Guo CH, Li FL, Xu RP, et al. Using health insurance reimbursement data to identify incident cancer cases. J Clin Epidemiol 2019;114:141 − 9. http://dx.doi.org/10.1016/j.jclinepi.2019.06.009CrossRef
|
|
[6]
|
Tian HR, Xu RP, Li FL, Guo CH, Zhang LX, Liu Z, et al. Identification of cancer patients using claims data from health insurance systems: a real-world comparative study. Chin J Cancer Res 2019;31(4):699 − 706. http://dx.doi.org/10.21147/j.issn.1000-9604.2019.04.13CrossRef
|
|
[7]
|
Tian HR, Yang W, Hu YJ, Liu Z, Chen L, Lei L, et al. Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China. EClinicalMedicine 2020;20:100312. http://dx.doi.org/10.1016/j.eclinm.2020.100312CrossRef
|
|
[8]
|
Yang L, Yuan YN, Sun TT, Li HC, Wang N. Population-based cancer incidence analysis in Beijing, 2008-2012. Chin J Cancer Res 2015;27(1):13 − 21. http://dx.doi.org/10.3978/j.issn.1000-9604.2015.01.07CrossRef
|
|
[9]
|
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al. Cancer Incidence in Five Continents, Vol. XI. Lyon: International Agency for Research on Cancer; 2021. IARC Scientific Publications, No. 166. https://publications.iarc.fr/Databases/Iarc-Cancerbases/Cancer-Incidence-In-Five-Continents-Vol.-XI-2017.https://publications.iarc.fr/Databases/Iarc-Cancerbases/Cancer-Incidence-In-Five-Continents-Vol.-XI-2017 |
|
[10]
|
Liu S, Yang L, Yuan YN, Li HC, Tian J, Lu SJ, et al. Cancer incidence in Beijing, 2014. Chin J Cancer Res 2018;30(1):13 − 20. http://dx.doi.org/10.21147/j.issn.1000-9604.2018.01.02CrossRef
|
|
[11]
|
Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer registration: principles and methods. Lyon: International Agency for Research on Cancer; 1991. IARC Scientific Publication No. 95. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Cancer-Registration-Principles-And-Methods-1991.https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Cancer-Registration-Principles-And-Methods-1991 |
|
[12]
|
Ji JF. Beijing cancer registry annual report 2020. Beijing: Peking University Medical Press. 2021. (In Chinese). |
|
[13]
|
Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 2009;45(5):747 − 55. http://dx.doi.org/10.1016/j.ejca.2008.11.032CrossRef
|
|
[14]
|
Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 2009;45(5):756 − 64. http://dx.doi.org/10.1016/j.ejca.2008.11.033CrossRef
|
|
[15]
|
National Cancer Center. Chinese guideline for cancer registration. Beijing: People’s Medical Publishing House. 2016. (In Chinese). |